v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities    
Net income $ 446.1 $ 487.7
Income from discontinued operations, net of tax (11.6) 0.0
Adjustments to reconcile net income from continuing operations to net cash provided by (used for) operating activities    
Equity income of unconsolidated subsidiaries (1.1) (0.8)
Depreciation 44.7 44.7
Amortization 46.5 42.4
Deferred income taxes 2.1 20.8
Loss on sale of business 0.0 26.3
Share-based compensation 23.6 27.3
Asset impairment and write-offs 0.0 48.5
Amortization of bridge financing fees 4.9 0.0
Changes in assets and liabilities, net of effects of business acquisitions    
Accounts receivable 169.2 56.7
Inventories (24.9) (45.7)
Other current assets (9.7) (35.8)
Accounts payable (8.7) 31.2
Employee compensation and benefits (11.7) (9.4)
Other current liabilities 2.7 60.8
Other non-current assets and liabilities 1.6 9.3
Net cash provided by operating activities 673.7 764.0
Investing activities    
Capital expenditures (54.2) (45.1)
Purchase of investments 0.0 (18.0)
Proceeds from sale of property and equipment 0.4 0.1
Acquisitions, net of cash acquired 0.0 (292.2)
Other (1.5) 0.9
Net cash used for investing activities (55.3) (354.3)
Financing activities    
Net repayments of short-term borrowings 0.0 (9.3)
Net (repayments) borrowings of revolving long-term debt (77.0) 210.5
Proceeds from long-term debt 500.0 0.0
Repayments of long-term debt (575.0) (269.3)
Debt issuance costs (8.9) (2.2)
Payment of contingent consideration (3.6) 0.0
Shares issued to employees, net of shares withheld (9.2) (2.2)
Repurchases of ordinary shares (350.0) (175.0)
Dividends paid (130.8) (123.3)
Net cash used for financing activities (654.5) (370.8)
Effect of exchange rate changes on cash and cash equivalents 8.5 (29.2)
Change in cash and cash equivalents (27.6) 9.7
Cash and cash equivalents, beginning of period 101.6 118.7
Cash and cash equivalents, end of period $ 74.0 $ 128.4